Literature DB >> 12692255

Role of N glycosylation of hepatitis B virus envelope proteins in morphogenesis and infectivity of hepatitis delta virus.

Camille Sureau1, Chantal Fournier-Wirth, Patrick Maurel.   

Abstract

Hepatitis delta virus (HDV) particles are coated with the large (L), middle (M), and small (S) hepatitis B virus envelope proteins. In the present study, we constructed glycosylation-defective envelope protein mutants and evaluated their capacity to assist in the maturation of infectious HDV in vitro. We observed that the removal of N-linked carbohydrates on the S, M, and L proteins was tolerated for the assembly of subviral hepatitis B virus (HBV) particles but was partially inhibitory for the formation of HDV virions. However, when assayed on primary cultures of human hepatocytes, virions coated with S, M, and L proteins lacking N-linked glycans were infectious. Furthermore, in the absence of M, HDV particles coated with nonglycosylated S and L proteins retained infectivity. These results indicate that carbohydrates on the HBV envelope proteins are not essential for the in vitro infectivity of HDV.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12692255      PMCID: PMC153980          DOI: 10.1128/jvi.77.9.5519-5523.2003

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  36 in total

Review 1.  Hepatitis delta virus: molecular biology, pathogenesis and immunology.

Authors:  J L Casey
Journal:  Antivir Ther       Date:  1998

Review 2.  Hepatitis D: virology, clinical and epidemiological aspects.

Authors:  M Rizzetto
Journal:  Acta Gastroenterol Belg       Date:  2000 Apr-Jun       Impact factor: 1.316

3.  Chaperones involved in hepatitis B virus morphogenesis.

Authors:  R Prange; M Werr; H Löffler-Mary
Journal:  Biol Chem       Date:  1999-03       Impact factor: 3.915

4.  N-linked glycosylation of hepatitis B surface antigens is involved but not essential in the assembly of hepatitis delta virus.

Authors:  C J Wang; S Y Sung; D S Chen; P J Chen
Journal:  Virology       Date:  1996-06-01       Impact factor: 3.616

5.  Effect of mutations in the small envelope protein of hepatitis B virus on assembly and secretion of hepatitis delta virus.

Authors:  S Jenna; C Sureau
Journal:  Virology       Date:  1998-11-10       Impact factor: 3.616

6.  Isoprenylation mediates direct protein-protein interactions between hepatitis large delta antigen and hepatitis B virus surface antigen.

Authors:  S B Hwang; M M Lai
Journal:  J Virol       Date:  1993-12       Impact factor: 5.103

7.  Infectious hepatitis B virus variant defective in pre-S2 protein expression in a chronic carrier.

Authors:  D Fernholz; P R Galle; M Stemler; M Brunetto; F Bonino; H Will
Journal:  Virology       Date:  1993-05       Impact factor: 3.616

8.  Infection process of the hepatitis B virus depends on the presence of a defined sequence in the pre-S1 domain.

Authors:  J Le Seyec; P Chouteau; I Cannie; C Guguen-Guillouzo; P Gripon
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

9.  Role of the large hepatitis B virus envelope protein in infectivity of the hepatitis delta virion.

Authors:  C Sureau; B Guerra; R E Lanford
Journal:  J Virol       Date:  1993-01       Impact factor: 5.103

10.  Reproducible high level infection of cultured adult human hepatocytes by hepatitis B virus: effect of polyethylene glycol on adsorption and penetration.

Authors:  P Gripon; C Diot; C Guguen-Guillouzo
Journal:  Virology       Date:  1993-02       Impact factor: 3.616

View more
  21 in total

1.  Large hepatitis delta antigen is a novel clathrin adaptor-like protein.

Authors:  Cheng Huang; Shin C Chang; I-Chen Yu; Yeou-Guang Tsay; Ming-Fu Chang
Journal:  J Virol       Date:  2007-03-21       Impact factor: 5.103

2.  Molecular interactions between hepatitis B virus and delta virus.

Authors:  Elham Shirvani-Dastgerdi; Frank Tacke
Journal:  World J Virol       Date:  2015-05-12

3.  A tryptophan-rich motif in the carboxyl terminus of the small envelope protein of hepatitis B virus is central to the assembly of hepatitis delta virus particles.

Authors:  Isabelle Komla-Soukha; Camille Sureau
Journal:  J Virol       Date:  2006-05       Impact factor: 5.103

4.  Mapping of the hepatitis B virus pre-S1 domain involved in receptor recognition.

Authors:  Azeneth Barrera; Bernadette Guerra; Lena Notvall; Robert E Lanford
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

Review 5.  Molecular interactions of plant viral satellites.

Authors:  Uzma Badar; Srividhya Venkataraman; Mounir AbouHaidar; Kathleen Hefferon
Journal:  Virus Genes       Date:  2020-11-23       Impact factor: 2.332

6.  Infectivity determinants of the hepatitis B virus pre-S domain are confined to the N-terminal 75 amino acid residues.

Authors:  Matthieu Blanchet; Camille Sureau
Journal:  J Virol       Date:  2007-03-21       Impact factor: 5.103

7.  A function essential to viral entry underlies the hepatitis B virus "a" determinant.

Authors:  Jessica Salisse; Camille Sureau
Journal:  J Virol       Date:  2009-07-01       Impact factor: 5.103

8.  Hepatitis B surface antigen levels and sequences of natural hepatitis B virus variants influence the assembly and secretion of hepatitis d virus.

Authors:  Hsuan Hui Shih; King-Song Jeng; Wan-Jr Syu; Yi-Hsiang Huang; Chien-Wei Su; Wei-Li Peng; I-Jane Sheen; Jaw-Ching Wu
Journal:  J Virol       Date:  2007-12-19       Impact factor: 5.103

9.  The pre-S1 and antigenic loop infectivity determinants of the hepatitis B virus envelope proteins are functionally independent.

Authors:  Yann Le Duff; Matthieu Blanchet; Camille Sureau
Journal:  J Virol       Date:  2009-09-16       Impact factor: 5.103

10.  Serum-derived hepatitis C virus infection of primary human hepatocytes is tetraspanin CD81 dependent.

Authors:  Sonia Molina; Valerie Castet; Lydiane Pichard-Garcia; Czeslaw Wychowski; Eliane Meurs; Jean-Marc Pascussi; Camille Sureau; Jean-Michel Fabre; Antonio Sacunha; Dominique Larrey; Jean Dubuisson; Joliette Coste; Jane McKeating; Patrick Maurel; Chantal Fournier-Wirth
Journal:  J Virol       Date:  2007-10-17       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.